16
Sustainability is rooted in how we operate, innovate, and grow responsibly. From greener
manufacturing and responsible sourcing to water stewardship and community well-being,
we integrate sustainability into every aspect of our business.
As a global pharmaceutical company, we operate in an environment shaped by climate
change, resource intensity, regulatory expectations, and growing healthcare needs. At Lupin,
we understand this deeply and respond by reducing emissions, conserving water, minimizing
waste, and strengthening ethical governance, ensuring resilient operations while delivering
long-term value for not just people but also the environment.
This commitment is driven by a clear ESG framework that guides action and accountability,
aligned with Lupin's purpose. It shapes how we create impact for our planet, our people,
and our patients.
Catalyzing Planet in Action
Transforming Our People
Healing Patients
Catalyzing planet action by addressing
Our Goal
42% reduction in Scope 1 & 2 emissions from FY23
Target Year: 2030
Status: 41%
Our Goal
Ensure over 90% of our hazardous waste is managed sustainably
Target Year: Year over Year
Status: 91%
Our Goal
10% reduction in absolute water withdrawal from FY21
Target Year: 2030
Status: 10%
Our Goal
100% global sites to be covered by biodiversity assessment
Target Year: 2030
Status: 66%
Transforming our people through
Our Goal
15% women in top management
Target Year: 2030
Status: 12%
Our Goal
50,000 hours of employee volunteering
Target Year: 2030
Status: 35400+
Our Goal
Employee satisfaction score of 80%
Target Year: Every Year
Status: 85%
Our Goal
100% coverage of critical suppliers
Target Year: Every 3 Years
Status: 17%
Our Goal
Support 2.5 million beneficiaries with livelihood programs
Target Year: 2030
Status: 266,955
Healing patients through
Our Goal
20 launches + 3 filings
Target Year: 2028
Status
16
(14 launches + 2 filing)
Our Goal
Benefitting 300,000 patients
Target Year: 2030
Status
401,764
Our Goal
3 Mn patients
50,000 Healthcare professionals
Target Year: 2030
Status
980,000
Patients
73,500
Healthcare professionals
Our Goal
Diagnose 2 Mn+ patients for lung disease
5,000 women for breast cancer
Target Year: 2030
Status
1,243,005
lung disease
2,064
women
Our robust ESG governance framework integrates environmental and social priorities into a clear business strategy, ensuring accountability and execution across the enterprise. At the board level, the Sustainability and Corporate Social Responsibility (SCSR) Committee provides strategic direction and ensures focused management of ESG risks and opportunities aligned with our long-term goals.
Through continuous innovation, improvement, and accountability, Lupin demonstrates a deep commitment to creating sustainable value for generations to come. This dedication is anchored in protecting nature, empowering and inspiring people and improving patient lives through responsible and ethical healthcare solutions.
